Home / Drug shortages / Icosapent Ethyl Capsule

Icosapent Ethyl Capsule — FDA Drug Shortage

To Be Discontinued — Apotex Corp.

The FDA lists a drug shortage record for Icosapent Ethyl Capsule (capsule) from Apotex Corp. with status To Be Discontinued. The shortage was first posted on 04/01/2026.

Shortage Details

Status
To Be Discontinued
Company
Apotex Corp.
Package NDC
61474-9711-1
Dosage Form
Capsule
Presentation
Icosapent Ethyl, Capsule, 1 g (NDC 61474-9711-1)
Initial Posting
04/01/2026
Revised Date

FDA data resources